- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07592624
Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital. (MediT)
The goal of this RCT is to evaluate the effect of the instructional video on improving patient compliance and reducing medication errors. The study will include adult kidney transplant recipients (18 years or older) at Erasmus MC who have undergone a kidney transplantation starting January 2026.
The main questions it aims to answer:
The primary aim of this study is to assess whether our developed video instruction, compared with the traditional verbal instruction, both of which are given shortly before training during admission, reduces the number of medication errors in kidney transplant patients.
The study will also examine the correlation between patient characteristics (such as age, comorbidities, and language proficiency) and medication errors. Additionally, patient-reported medication errors will be measured through a questionnaire completed during follow-up visits at the outpatient clinic, which is part of standard care.
The instructional video will be evaluated by a short questionnaire.
Studienübersicht
Status
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Myrthe van der Zanden, MSc, Drs
- Telefonnummer: +31650094899
- E-Mail: m.vanderzanden@erasmusmc.nl
Studienorte
-
-
-
Rotterdam, Niederlande, 3015GD
- Erasmus Medical Center
-
Kontakt:
- Myrthe van der Zanden, MSc, Drs.
- Telefonnummer: +31650094899
- E-Mail: m.vanderzanden@erasmusmc.nl
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- The patient is able to take the medication independently or with the help of someone else (professionals not included).
- After admission, the patient is discharged to their own home or home of friend/relative.
- The patient had a follow up at the outpatient clinic in the Erasmus Medical Center for at least one year after transplantation.
- The patient is able to read the medication list or an illiteracy-friendly medication list.
Exclusion Criteria:
- Patients under 18 years of age
- Patients who got discharged with a medication dispenser
- Refusal to participate in the study.
- Cognitive impairments that hinder participation.
- Patients and/or family who can not understand (language barrier) the instructional video.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Verbal instruction
Patients receive the verbal instruction about medication training from the nurses.
|
|
|
Experimental: Video instruction
Patients receive the instruction video about medication training from the nurses.
|
Self developed instructional video for a Dutch university hospital, for Dutch kidney transplant patients.
Instructional video is about medication administration during admission.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Incidence and type of medication errors during admission
Zeitfenster: During admission
|
The primary outcome of this study will be the incidence (number of medication errors) and type of medication errors ( 1)Medication preparation omitted, 2) Incorrect dosage, 3) Incorrect administration at the scheduled time, 4), Medication discontinued inappropriately, 5)Error not documented by the nurse) during admission, evaluated through direct observation by healthcare providers.
These errors will be documented and reported via patient portals by nurses.
|
During admission
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient characteristics
Zeitfenster: During admission
|
Age (in years), gender (male/female/nonbinair), country of origin, language proficiency, number of previous organ transplantations, donor type of the kidney transplant (DCD, DBD, Living), and renal replacement therapy (HD/PD/Pre-emptive).
|
During admission
|
|
Evaluation of the instructional video
Zeitfenster: At the end of admission
|
Structured questionnaire with the following questions:
|
At the end of admission
|
|
BAASIS
Zeitfenster: During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC
|
Participants will complete a patient-reported questionnaire (BAASIS) every three months during the first year after transplantation. The questionnaire consists of five yes/no questions related to medication errors occurring in the home setting. The questions will ask whether the participant has:
The goal is to evaluate whether there is a reduction in home-reported medication errors for those who receive a different medication management training method in the hospital. |
During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienstuhl: Jacqueline van de Wetering, MD, Dr., Erasmus Medical Center
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 14372
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .